Perspective
Published on 24 Aug 2022
Switching Among Biosimilars: A Review of Clinical Evidence
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.917814
- 10,643 views
- 24 citations
Type at least 3 characters
1,948 articles
Articles
Original Research
Published on 24 Aug 2022
How do cancer clinicians perceive real-world data and the evidence derived therefrom? Findings from an international survey of the European Organisation for Research and Treatment of Cancer
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.969778
- 3,413 views
- 6 citations
Systematic Review
Published on 24 Aug 2022
Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.883251
- 34,400 views
- 9 citations
Original Research
Published on 24 Aug 2022
Potential drug-drug interactions in drug therapy for older adults with chronic coronary syndrome at hospital discharge: A real-world study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.946415
- 3,932 views
- 4 citations
Original Research
Published on 23 Aug 2022
Corporate social responsibility of pharmaceutical industry in Korea
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.950669
- 14,635 views
- 2 citations
Original Research
Published on 23 Aug 2022
The change of drug utilization in China’s public healthcare institutions under the “4 + 7” centralized drug procurement policy: Evidence from a natural experiment in China
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.923209
- 4,370 views
- 15 citations
Review
Published on 23 Aug 2022
Review of Urate-Lowering Therapeutics: From the Past to the Future
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.925219
- 13,870 views
- 23 citations
Original Research
Published on 23 Aug 2022
A bibliometric analysis of the 100 most-cited articles on curcumin
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.963032
- 3,198 views
- 11 citations
Original Research
Published on 22 Aug 2022
Atezolizumab plus platinum-based chemotherapy as first-line therapy for metastatic urothelial cancer: A cost-effectiveness analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.872196
- 1,954 views
- 4 citations
Original Research
Published on 22 Aug 2022
Physicians’ Knowledge, Altitudes, and Perceived Barriers of Inappropriate Prescribing for Older Patients in Shanghai, China
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.821847
- 1,958 views
- 1 citation
Original Research
Published on 22 Aug 2022
Adverse drug reactions and correlations with drug–drug interactions: A retrospective study of reports from 2011 to 2020
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.923939
- 11,932 views
- 29 citations
Original Research
Published on 22 Aug 2022
Current situation and future development of the biopharmaceutical industry in China: A mixed-method study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.911165
- 7,282 views
- 2 citations
Original Research
Published on 17 Aug 2022
The impacts of the “4+7” pilot policy on the volume, expenditures, and daily cost of Serotonin-Specific Reuptake Inhibitors (SSRIs) antidepressants: A quasi-experimental study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.829660
- 2,942 views
- 5 citations
Original Research
Published on 16 Aug 2022
Real-world association of adherence with outcomes and economic burden in patients with tuberculosis from South Korea claims data
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.918344
- 2,196 views
- 3 citations
Editorial
Published on 15 Aug 2022
Editorial: Leveraging pharmacovigilance data mining with “the patient” in mind
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.980645
- 1,449 views
Original Research
Published on 15 Aug 2022
Time to First Line Antiretroviral Therapy Adverse Drug Reaction and its Predictors Among Adult HIV/AIDS Patients on Treatment in Eastern Ethiopia
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.922744
- 2,728 views
- 1 citation